Venture-Backed Startups
101,671 companies with verified investor relationships.
BioFactura is a clinical-stage biopharmaceutical company developing biologics and biosimilars, and has launched Capitol Biologics, a CDMO division offering contract development and manufacturing services to advance biologics from concept to clinic.
0 investors
0 investors
BioFeyn is a life sciences company that applies biomedical nanoencapsulation technology (its "Feyn" delivery mechanism) to feed ingredients, improving nutrient absorption and bioavailability in animals. It focuses on aquaculture and agriculture, particularly salmon farming, serving farmers and feed suppliers while reducing waste and environmental impact.</parameter> <parameter name="founders">[{"full_name": "Timothy Bouley", "title": "CEO, Founder"}, {"full_name": "Marie-Christine Imbert", "title": "CSO, Founder"}]
2 investors
Biofidelity develops genomic biomarker testing technologies—its Aspyre and Enspyre products—for cancer detection, treatment selection, and minimal residual disease monitoring. The company serves oncology providers and patients with precision genomic diagnostics across the cancer patient journey.
3 investors
Biofine holds a patent portfolio for a technology that converts waste lignocellulosic feedstocks into renewable chemicals, carbon-negative biofuels, and biochar. The company operates a pilot plant in Maine and is developing its first commercial biorefinery in Lincoln, Maine, for the industrial bioeconomy.
0 investors
0 investors
Revolutionising the textile industry by pioneering a new era of plant-based alternatives to animal and synthetic derived materials
2 investors
0 investors
Bioflyte provides chemical and biological threat detection solutions for critical infrastructure and business operations, enabling organizations to monitor, identify and respond to bio/chem threats. The company serves government agencies, critical infrastructure operators, and other organizations responsible for security and safety.
3 investors
Biofourmis provides technology-enabled solutions and a platform for AI-driven in-home patient care, using wearable biosensors and remote monitoring to deliver and transition patients across levels of care. It serves healthcare providers and partners, aiming to reduce hospital readmissions and cost of care.
1 investor
0 investors
Biogen is a biotechnology company founded in 1978 that focuses on breakthroughs in biology. The company serves patients through research and development in the life sciences industry.
3 investors
BIOGENA develops premium micronutrient supplements, functional drinks, and longevity services for consumer health and wellness across different life stages. The company manufactures products in Austria focused on scientific efficacy, purity, and quality standards.
1 investor
0 investors
0 investors
0 investors
Bioglitz produces a plant-based glitter adhesive and skincare serum made from algae that holds cosmetic glitz designs while moisturizing skin. The product is marketed as a beauty and personal care item for consumers seeking long-lasting glitter looks.
1 investor
1 investor
BioGrip develops non-invasive neuromuscular sensing technology combined with adaptive AI to decode human intention and enable intuitive control of prosthetics, rehabilitation systems, and robotics. The company targets individuals with mobility impairments and muscular or peripheral nerve damage.
2 investors
Biogroup is a network of medical biology laboratories that provides diagnostic testing and lab services to patients. It emphasizes proximity and quality of care across its locations in France.
1 investor
A community biotechnology laboratory in Ecuador that democratizes access to life sciences education and research. It provides training, workspace, and support for students and entrepreneurs interested in biotechnology and experimental sciences.
1 investor
Biohaven is a biopharmaceutical company developing treatments in immunology, obesity, neuroscience, and oncology, with approved migraine therapies and a pipeline of early-to-late-stage drug development programs.
3 investors
0 investors
Biohaven is a biopharmaceutical company focused on discovering and developing treatments in immunology, obesity, neuroscience, and oncology, including approved migraine medications. The company advances therapeutic programs for diseases with significant unmet medical needs.
4 investors